Pacira Pharmaceuticals (PCRX) Technical (Analysis) Reports Pacira Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Pacira Pharmaceuticals (PCRX)
Technical Analysis Report for NASDAQ stock PCRX Pacira Pharmaceuticals. Dated: 05 Dec 2025 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PCRX Pacira Pharmaceuticals then click here. or read Experts views on Pacira Pharmaceuticals or Forecast & share price targets of Pacira Pharmaceuticals
Pacira Pharmaceuticals Opened at 23.95 and Closed at: 23.99, which is 0.04% of previous session's close. It moved within a range of 23.92 and 24.32
The session was a Bullish session with an average volume of 424000, which is -35.31% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 23.96 and resistance for tomorrow is 24.36
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 23.83, 23.68 resistance for tomorrow's hourly charts is 24.23, 24.48
10 Day SMA for Pacira Pharmaceuticals (PCRX) is 23.67 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Pacira Pharmaceuticals (PCRX) is 23.63 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Pacira Pharmaceuticals (PCRX) is 23.14 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 24.02 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Pacira Pharmaceuticals is 24.34 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Pacira Pharmaceuticals is at 23.63 and 200 DMA is at 24.34, while 50 DMA and 100 DMA are at 23.14 and 24.02 respectively
Pacira Pharmaceuticals (PCRX) moving average of 20 SMA is at 23.63 and 20 EMA is at 23.53
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Fri Dec | 23.99 | 23.63 | 23.53 |
| 04 Thu Dec | 23.98 | 23.49 | 23.48 |
| 03 Wed Dec | 24.19 | 23.38 | 23.43 |
| 02 Tue Dec | 24.07 | 23.29 | 23.35 |
| 01 Mon Dec | 23.70 | 23.16 | 23.27 |
| 28 Fri Nov | 23.57 | 23.04 | 23.23 |
Pacira Pharmaceuticals (PCRX) moving average of 50 SMA is at 23.14 and 50 EMA is at 23.53
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Fri Dec | 23.99 | 23.14 | 23.53 |
| 04 Thu Dec | 23.98 | 23.17 | 23.51 |
| 03 Wed Dec | 24.19 | 23.22 | 23.49 |
| 02 Tue Dec | 24.07 | 23.26 | 23.46 |
| 01 Mon Dec | 23.70 | 23.3 | 23.44 |
| 28 Fri Nov | 23.57 | 23.36 | 23.43 |
Pacira Pharmaceuticals (PCRX) moving average of 100 SMA is at 24.02 and 100 EMA is at 23.82
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Fri Dec | 23.99 | 24.02 | 23.82 |
| 04 Thu Dec | 23.98 | 24.01 | 23.82 |
| 03 Wed Dec | 24.19 | 23.99 | 23.82 |
| 02 Tue Dec | 24.07 | 23.98 | 23.81 |
| 01 Mon Dec | 23.70 | 23.97 | 23.8 |
| 28 Fri Nov | 23.57 | 23.97 | 23.8 |
Pacira Pharmaceuticals (PCRX) moving average of 200 SMA is at 24.34 and 200 EMA is at 23.66
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Fri Dec | 23.99 | 24.34 | 23.66 |
| 04 Thu Dec | 23.98 | 24.35 | 23.66 |
| 03 Wed Dec | 24.19 | 24.37 | 23.66 |
| 02 Tue Dec | 24.07 | 24.37 | 23.65 |
| 01 Mon Dec | 23.70 | 24.38 | 23.65 |
| 28 Fri Nov | 23.57 | 24.4 | 23.65 |
Pacira Pharmaceuticals has performed better than Zynex Inc in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Utah Medical in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Staar Surgical in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Summit Therapeutics in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Sintx Technologies has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Sintx Technologies, about 14.44% more returns!
Pacira Pharmaceuticals has performed better than Siga Technologies in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Insulet Corporation in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Nature S has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Nature S, about 13.3% more returns!
Lantheus Holdings has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Lantheus Holdings, about 15.15% more returns!
Kodiak Sciences has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Kodiak Sciences, about 29.26% more returns!
Acadia Pharmaceuticals has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Acadia Pharmaceuticals, about 12.73% more returns!
Pacira Pharmaceuticals has performed better than Apyx Medical in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Assembly Biosciences has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Assembly Biosciences, about 3.41% more returns!
Pacira Pharmaceuticals has performed better than Compugen in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Celldex Therapeutics has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Celldex Therapeutics, about 19.8% more returns!
Pacira Pharmaceuticals has performed better than Corbus Pharmaceuticals in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Cytokinetics Incorporated has performed better than Pacira Pharmaceuticals in short term. You could have earned much better returns by investing in Cytokinetics Incorporated, about 0.36% more returns!
Pacira Pharmaceuticals has performed better than Ensign Group in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals has performed better than Henry Schein in short term. Holding Pacira Pharmaceuticals could be a better choice for now!
Pacira Pharmaceuticals Technical analysis of indicators
Price action analysis of Pacira Pharmaceuticals (PCRX) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Pacira Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is losing momentum.
MACD generated a BUY signal for Pacira Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Pacira Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Pacira Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Pacira Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 23.62 and Pacira Pharmaceuticals PCRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Pacira Pharmaceuticals PCRX stock. Volume based technical analysis of Pacira Pharmaceuticals PCRX stock is negative.
Pacira Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PCRX Pacira Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PCRX Experts View which covers a lot of information including buying and selling signals
PCRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Pacira Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Pacira Pharmaceuticals (PCRX) Technical (Analysis) Reports Pacira Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


